Martin Felices

Company: University of Minnesota

Job title: Associate Professor of Medicine

Seminars:

1.00 Expanding Beyond Bispecific & T Cells to Address Tumor Heterogeneity 1:00 pm

Currently the only approved cell engagers are designed exclusively for T cells. Natural killer (NK) cells are being leveraged in the clinic due to their safety profile and their ability to mediate tumor killing without prior priming. However, lack of antigen-specific targeting, decreased numbers, and suppressive signals derived from the tumor microenvironment (TME) can impact…Read more

day: Workshop C